News for Codexis, Inc. (CDXS)

On March 5, 2025, Opaleye Management Inc. (Trades, Portfolio) made a strategic move by acquiring an additional 260,000 shares of Codexis Inc. (CDXS). This trans

Codexis, Inc. (NASDAQ:CDXS) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsCarrie McKim - Director of Investor...

REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. ( CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeuti

REDWOOD CITY, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable the

Discover Codexis' latest employee equity grants under their 2024 inducement plan. Learn about stock options, restricted units & new hires.

On December 31, 2024, Opaleye Management Inc. (Trades, Portfolio) executed a significant transaction involving Ocular Therapeutix Inc. The firm reduced its hold

Opaleye Management Inc. (Trades, Portfolio) recently executed a significant stock transaction, acquiring an additional 375,000 shares of iBio Inc. on December 3

Opaleye Management Inc. (Trades, Portfolio)'s Recent Acquisition On December 31, 2024, Opaleye Management Inc. (Trades, Portfolio) executed a strategic stock tr

REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. ( CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeu

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

On January 22, 2025, Opaleye Management Inc. (Trades, Portfolio) executed a substantial reduction in its holdings of Harrow Inc., a U.S.-based eyecare pharmaceu

**media[517340,517341]**

REDWOOD CITY, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. ( CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeuti

**media[504207,504208]**

Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. ( CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical compan

**media[485658]**

REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. ( CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeuti